Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,957 | 228 | 86.0% |
| Education | $642.30 | 8 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $971.52 | 52 | $0 (2024) |
| ABBVIE INC. | $630.60 | 47 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $541.89 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $378.75 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $368.55 | 15 | $0 (2024) |
| Amgen Inc. | $327.85 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $174.05 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $157.00 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $151.98 | 2 | $0 (2022) |
| Galderma Laboratories, L.P. | $119.01 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,325 | 70 | Regeneron Healthcare Solutions, Inc. ($243.88) |
| 2023 | $1,207 | 53 | Janssen Biotech, Inc. ($315.84) |
| 2022 | $1,261 | 61 | ABBVIE INC. ($282.60) |
| 2021 | $805.97 | 52 | AbbVie Inc. ($235.91) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Immunology | ||||||
| 10/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $42.99 | General |
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Immunology | ||||||
| 09/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Oncology | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $44.95 | General |
| Category: Obesity | ||||||
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $91.61 | General |
| 09/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Immunology | ||||||
| 08/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,720 | 6,968 | $216,622 | $118,603 |
| 2022 | 21 | 1,741 | 13,204 | $230,900 | $135,850 |
| 2021 | 20 | 1,918 | 14,024 | $222,231 | $128,619 |
| 2020 | 18 | 1,810 | 3,069 | $183,694 | $100,180 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 387 | 567 | $48,792 | $28,743 | 58.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 215 | $26,130 | $15,427 | 59.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 191 | 219 | $22,903 | $12,721 | 55.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 159 | 181 | $17,040 | $8,663 | 50.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 75 | 204 | $9,618 | $6,222 | 64.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 139 | 176 | $11,103 | $4,893 | 44.1% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 12 | 4,200 | $6,300 | $4,704 | 74.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $7,032 | $3,705 | 52.7% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 55 | 97 | $9,071 | $3,417 | 37.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 40 | 63 | $7,083 | $3,144 | 44.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 42 | $5,321 | $2,549 | 47.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 12 | 21 | $5,494 | $2,541 | 46.3% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 29 | 48 | $5,149 | $2,294 | 44.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $3,775 | $2,275 | 60.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 59 | $3,147 | $1,917 | 60.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $2,962 | $1,913 | 64.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 25 | 25 | $2,885 | $1,889 | 65.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 87 | 452 | $2,928 | $1,703 | 58.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 20 | 27 | $3,657 | $1,661 | 45.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 17 | $2,987 | $1,624 | 54.3% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 23 | 38 | $3,705 | $1,396 | 37.7% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 18 | $2,279 | $1,338 | 58.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $2,148 | $1,191 | 55.5% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 17 | 18 | $2,044 | $1,123 | 54.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 27 | $1,463 | $750.21 | 51.3% |
About Sandra Cox, ARNP
Sandra Cox, ARNP is a Dermatology healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215976220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Cox, ARNP has received a total of $4,599 in payments from pharmaceutical and medical device companies, with $1,325 received in 2024. These payments were reported across 236 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,957).
As a Medicare-enrolled provider, Cox has provided services to 7,189 Medicare beneficiaries, totaling 37,265 services with total Medicare billing of $483,252. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Owensboro, KY
- Active Since 06/05/2006
- Last Updated 06/04/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1215976220
Products in Payments
- TREMFYA (Drug) $861.68
- DUPIXENT (Biological) $476.79
- SKYRIZI (Biological) $338.42
- COSENTYX (Drug) $314.19
- ILUMYA (Biological) $309.59
- Otezla (Drug) $264.68
- RINVOQ (Biological) $195.52
- Sotyktu (Drug) $157.00
- REMICADE (Biological) $109.84
- AMELUZ (Drug) $107.09
- BREZTRI (Drug) $97.65
- HUMIRA (Biological) $88.25
- AMZEEQ (Drug) $87.41
- Epclusa (Drug) $76.04
- TALTZ (Drug) $68.02
- Odomzo (Drug) $63.28
- NUCALA (Biological) $57.87
- OPZELURA (Drug) $56.86
- FARXIGA (Drug) $54.33
- EVENITY (Biological) $51.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Owensboro
Dr. Artis Truett, M.d, M.D
Dermatology — Payments: $23,260
Dr. Cassey Vessels, M.d. (May 2008), M.D. (MAY 2008)
Dermatology — Payments: $2,248
Dr. Michael Crowe, M.d, M.D
Dermatology — Payments: $2,187
Dr. Nicole Brey, M.d, M.D
Dermatology — Payments: $949.53